nasal cannula market research, nasal cannula market demand, nasal cannula market analysis, nasal cannula market segments, nasal cannula market drivers, nasal cannula market scope
What is the current size and annual growth rate of the nasal cannula market?
The nasal cannula market size has grown strongly in recent years. It will grow from $8.93 billion in 2024 to $9.82 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increasing personalized patient care, increasing prevalence of obstructive sleep apnea, increasing awareness of respiratory diseases, rising changes in lifestyle, and rising population.
The nasal cannula market size is expected to see strong growth in the next few years. It will grow to $14.17 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to the increasing prevalence of respiratory diseases, increasing healthcare expenditure, increasing geriatric population, increasing government initiatives, and increasing number of surgeries. Major trends in the forecast period include technological advancement, strategic collaboration, facility expansion, investment in research and development, and focus on product launch.
Get Your Free Sample of The Global Nasal Cannula Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20895&type=smp
Which major factors have contributed to the expansion of the nasal cannula market?
The increasing number of respiratory diseases is significantly contributing to the growth of the nasal cannula market. Respiratory diseases are medical conditions that affect the lungs and airways, impairing breathing and oxygen exchange. Rises in respiratory diseases can be attributed to factors such as air pollution, smoking, viral infections, and increased exposure to allergens. A nasal cannula is used in respiratory diseases to deliver supplemental oxygen directly into the nostrils, improving oxygen levels in patients with breathing difficulties. For instance, in June 2024, according to the American Lung Association, a US-based non-profit organization, in 2022, approximately 44.2 million Americans, constituting 13.5% of the population, reported having received a diagnosis of asthma from a qualified health professional. Therefore, the increasing number of respiratory diseases drives the growth of the nasal cannula market.
How is the nasal cannula market segmented?
The nasal cannula market covered in this report is segmented –
1) By Type: Low Flow Nasal Cannula, High Flow Nasal Cannula
2) By Material: Plastic, Silicone
3) By Size: Neonate, Infant, Child, Adult
4) By Prongs: Straight, Curved, Flared, Other Prongs
5) By End User: Hospitals, Ambulatory Healthcare Services, Long Term Care Centers, Others End Users
Subsegments:
1) By Low Flow Nasal Cannula: Adult Low Flow Nasal Cannula, Pediatric Low Flow Nasal Cannula, Disposable Low Flow Nasal Cannula, Reusable Low Flow Nasal Cannula
2) By High Flow Nasal Cannula: Adult High Flow Nasal Cannula, Pediatric High Flow Nasal Cannula, Disposable High Flow Nasal Cannula, Reusable High Flow Nasal Cannula
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/nasal-cannula-global-market-report
Who are the top competitors in the nasal cannula market?
Major companies operating in the nasal cannula market are Cardinal Health Inc., Medline Industries Inc., Becton Dickinson and Company, ResMed Inc., Teleflex Incorporated, Angiplast Pvt. Ltd., Fisher & Paykel Healthcare Limited, Drive DeVilbiss Healthcare LLC, Well Lead Medical Co. Ltd., GaleMed Corp., Vapotherm Inc., Salter Labs Inc., Dynarex Corporation, Mais India Medical Devices Pvt. Ltd., Allied Medical LLC, Besmed Health Business Corp., Flexicare Medical Ltd., Medin Medical Innovations AB, Airways Surgical Pvt. Ltd., Great Group Medical Co. Ltd., HUM GmbH
Which key trends are expected to influence the nasal cannula market in the coming years?
Major companies operating in the nasal cannula market are focusing on technological innovations, such as low-flow nasal cannulas, to enhance patient comfort, improve oxygen delivery efficiency, and meet specific clinical requirements. A low-flow nasal cannula is a device designed to deliver supplemental oxygen at lower flow rates, usually ranging from 1 to 6 liters per minute, through two prongs inserted into the nostrils. For instance, in May 2024, CNSAC MedShop, a Germany-based diagnostics and consumables company, introduced NasalOxy, a revolutionary, patented low-flow nasal cannula designed to address the limitations of traditional oxygen delivery methods. This innovative device provides unparalleled comfort and effectiveness for patients requiring long-term oxygen therapy while also offering versatility for supporting both nasal and oral breathing. The advanced design of NasalOxy reduces contact with the mucous membrane, thereby minimizing irritation and discomfort and eliminating common side effects associated with traditional nasal cannulas.
Which regional trends are influencing the nasal cannula market, and which area dominates the industry?
North America was the largest region in the nasal cannula market in 2024. The regions covered in the nasal cannula market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Nasal Cannula Market Report 2025 Offer?
The nasal cannula market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
A nasal cannula is a medical device used to deliver supplemental oxygen to patients who require respiratory support. It consists of two small prongs that fit into the nostrils, connected by a thin tube to an oxygen source. This device allows for comfortable, continuous oxygen flow while enabling the patient to speak and eat.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20895
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
